ALETA BIOTHERAPEUTICS
Aleta Biotherapeutics is an immuno-oncology company focused on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be targeted. The company was founded in 2015 and is headquartered in Natick, Massachusetts, United States.
ALETA BIOTHERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
Natick, Massachusetts, United States
Country:
United States
Website Url:
http://www.aletabio.com
Total Employee:
1+
Status:
Active
Contact:
(508) 282-6370
Total Funding:
13.72 M USD
Technology used in webpage:
Organization Schema CrUX Dataset CrUX Top 50m
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Employees Featured
Founder
Investors List
Viva BioInnovator
Viva BioInnovator investment in Series A - Aleta Biotherapeutics
Advent Life Sciences
Advent Life Sciences investment in Venture Round - Aleta Biotherapeutics
Official Site Inspections
http://www.aletabio.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Aleta Biotherapeutics"
Aleta Biotherapeutics - Crunchbase Company Profile
Aleta Biotherapeutics is an immuno-oncology company focused on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be …See details»
Aleta Biotherapeutics - LinkedIn
Aleta Biotherapeutics | 986 followers on LinkedIn. Aleta’s mission is to create cell therapeutics that provide robust and durable clinical benefit for patients. | Aleta’s mission is to create ...See details»
Aleta BioTherapeutics Company Profile | Management and
Www.aletabio.com . Aleta BioTherapeutics Profile and History. Aleta Biotherapeutics is an immuno-oncology company focused on transforming cellular therapeutics to allow a broad …See details»
Aleta BioTherapeutics - Overview, News & Similar companies
Nov 6, 2022 Who is Aleta BioTherapeutics. Aleta Biotherapeutics is an immuno-oncology company focused on transforming cellular therapeutics to allow a broad spectrum of cancer …See details»
Aleta Biotherapeutics Company Profile: Overview and Full News …
Aletabio.com. Overview: Aleta Biotherapeutics. Aleta Biotherapeutics, located in Massachusetts, is a pioneering company in the field of cancer treatment, specifically focusing on enhancing …See details»
Aleta Biotherapeutics - PitchBook
Aleta Biotherapeutics General Information Description. Developer of immuno-oncology drugs intended to treat intractable cancerous tumors. The company's drugs transform cellular therapeutics to permit a broad spectrum of tumor …See details»
Aleta Biotherapeutics - Products, Competitors, Financials, …
Headquarters Location. 27 Strathmore Road . Natick, Massachusetts, 01760, United States. 508-282-6370See details»
Aleta BioTherapeutics | Viva BioInnovator
Viva BioInnovator. No. 50, Lane 63, Faraday Road, Zhangjiang High-Tech Park, Shanghai, 201203, China.See details»
Aleta Biotherapeutics Company Profile | Natick, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Aleta Biotherapeutics of Natick, MA. Get the latest business insights from Dun & Bradstreet.See details»
Aleta BioTherapeutics - Craft
Aleta BioTherapeutics has 1 employees at their 1 location. See insights on Aleta BioTherapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Aleta Biotherapeutics - VentureRadar
Similar Companies: Asymmetrex USA n/a Asymmetrex, LLC is a for-profit limited liability company with a mission of advancing innovative adult tissue stem cell technologies to applications in …See details»
Aleta Biotherapeutics Receives Innovation Passport Designation …
Nov 7, 2022 Karen LaRochelle, MBA Chief Business Officer Aleta Biotherapeutics [email protected]. Release Summary.See details»
Aleta Biotherapeutics Announces ALETA-001 Presentation at 63rd …
Nov 9, 2021 To discover more about our mission, technologies and pipeline please visit www.aletabio.com. To learn more about the work being done by Cancer Research UK please …See details»
Aleta Biotherapeutics and Cancer Research UK collaborate to …
NATICK, Mass., June 23, 2021 – Aleta Biotherapeutics (‘Aleta’) and Cancer Research UK today announced a collaboration to advance the early phase clinical development of Aleta’s CAR-T …See details»
Aleta Biotherapeutics and Cancer Research UK’s Centre for Drug ...
Feb 21, 2024 aletabio.com. About Cancer Research UK’s Centre for Drug Development. Cancer Research UK has an impressive record of developing novel treatments for cancer. The Cancer …See details»
Aleta Biotherapeutics Receives Innovation Passport Designation …
NATICK, Mass., November 7, 2022 – Aleta Biotherapeutics (Aleta), a privately held immuno-oncology company with novel biologic CAR T engagers that work in synergy with cell therapies …See details»
Aleta Biotherapeutics Granted MHRA Clinical Trial Authorization …
Aug 8, 2023 Aleta’s lead program, ALETA-001 has clinical support from collaborator Cancer Research UK, which will initiate the Phase 1/2 Clinical Trial during H2 2023 ALETA-001, …See details»
What is Aleta BioTherapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Aleta BioTherapeutics. Salaries, reviews, and more - all posted by employees working at Aleta BioTherapeutics.See details»
Aleta Biotherapeutics Receives Innovation Passport Designation …
Nov 7, 2022 Designation Intends to Accelerate Regulatory Review Process and Facilitate U.K. Patient Access to Medicines for Seriously Debilitating and Life-Threatening Diseases …See details»